AstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a ...

Can I go to Europe this summer? 2021? The New York Times Article: <a href=" The playlist <a href=" YEAH!!! Europe is open to ...

The EC granted conditional approval based on activity seen in a subset of IHC 3+ HER2-positive advanced biliary tract cancer patients in a Phase II trial.

This approval comes almost a year after the drug received a complete response letter due to third-party manufacturing issues.

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

Traditional and new laboratory tools along with advances in AI are outlining a new paradigm in human disease modeling.

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...

COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and ...

As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer ...